Vlad Andreev, mental health educator and executive coach, founder of O!Sapiens. Education, not medical advice.
You can still perform, but it costs more than it used to. The reports get finished, the calls get taken, yet holding attention through the back half of a long block feels like pushing a car that used to roll on its own. Most executives file this under fatigue or age and move on. Sometimes it is neither. Sometimes it is a supply problem in the raw material your brain and heart are built from, and it is one of the few things you can put an actual number on.
Omega-3 status is a measurable input that sets part of the baseline your brain and cardiovascular system run on, and a low level is a form of hidden biological debt you can see in a single blood test rather than infer from how you feel.
Roughly 76% of people do not carry enough EPA and DHA, the two long-chain omega-3 fats that matter most, according to 2025 global status estimates. In the US, average intake runs near 41 mg of EPA and 72 mg of DHA a day, a small fraction of what most guidance points toward. This is not an exotic deficiency. It is close to the default.
What is actually happening in the tissue?
DHA is not a nice-to-have nutrient floating in your bloodstream. It is a structural component of the membranes your neurons are built from. Membrane composition affects how fluid those membranes are, how cleanly signals pass across synapses, and how well the machinery of a brain cell does its work. When DHA supply is chronically low, the body builds those membranes out of whatever is available, and the substitute materials do not perform the same way.
EPA does a different job. It is a raw material for the molecules that resolve inflammation, and it competes directly with omega-6 fats that push the other direction. A diet heavy in processed food and seed oils and light in fatty fish tilts that balance toward a low-grade inflammatory setting. Your brain and your arteries both operate inside that setting all day.
This is why the same deficit shows up in two systems at once. The cognitive cost and the cardiovascular cost are not separate stories. They are the same supply line feeding two different pieces of your performance infrastructure.
What can you actually measure?
Here is where omega-3 separates itself from most of what gets sold as brain support. There is a validated blood marker, the Omega-3 Index, which measures the EPA and DHA content of your red blood cell membranes as a percentage. It reflects your status over months, not what you ate yesterday, so it is a genuine baseline reading rather than a snapshot.
The number tracks hard outcomes. In a 2025 analysis published in the Journal of Clinical Lipidology, following 2,550 people without cardiovascular disease over ten years, those in the highest Omega-3 Index band (above 6.8%) had a 34% lower risk of death from any cause and a 39% lower risk of a first cardiovascular event compared with those in the lowest (below 4.2%). Omega-3 status held its own alongside long-established risk factors like cholesterol and smoking. That is a rare thing for a nutrient marker.
On the cognitive side, a 2025 dose-response meta-analysis in Scientific Reports pooling 58 studies found that each additional 2,000 mg per day of omega-3 was associated with measurable improvement in attention and perceptual speed, with executive-function benefit concentrated in the first year of consistent intake and strongest in people whose starting levels were not already adequate.
What does the signal mean, and what does it not?
Read the last clause of that finding carefully, because it is the whole game. The benefit shows up mostly in people who were low to begin with. If your level is already in a good range, adding more does little. This is a correction, not an upgrade.
That single fact explains why the headlines look contradictory. Large trials that hand omega-3 to everyone regardless of starting status show mixed, often unimpressive results, while the blood level itself remains a strong predictor of who does well. Both are true. Averaging a group of already-replete people with a group of deficient people washes out an effect that is real in the ones who needed it. The pill count is not the signal. The blood level is.
The second boundary: what moves is attention and processing speed, the ability to hold and sort information over time. This is not a pill that makes you smarter or hands you an extra ten IQ points. It supports the specific function that fades first under load. Do not expect a euphoric switch. A stimulant gives you that feeling by borrowing against recovery capacity. This is the opposite kind of input, quiet and structural.
A word of caution on the marketed version of all this. Omega-3 blood panels are now bundled into expensive executive-health packages alongside dozens of other tests. The value of a test is the share of its findings that are real and actionable, not the length of the report. One relevant, cheap, repeatable marker beats a forty-line panel you will never act on.
What is the minimum that actually moves the number?
The food-first version is genuinely simple. Two to three servings of fatty fish a week (salmon, sardines, mackerel, herring) covers most of the gap for most people, no capsules required. That is a grocery decision, not a supplement regimen.
If fish is not realistic at that frequency, a combined EPA and DHA supplement in the range of roughly 1 to 2 grams a day is the studied territory. Buy on the actual EPA and DHA content listed on the label, not the total fish-oil weight on the front, and treat plain formulations the same way you would any commodity: the branded premium usually buys marketing, not effect. Take it with a meal that contains fat, since absorption depends on it.
Then give it time and check the result. Red blood cell membranes turn over slowly, so the Omega-3 Index responds over two to three months, not two to three days. Test once, adjust intake, retest a season later, and let the trend rather than a single reading tell you whether it worked. That is three to four minutes of blood draw twice a year against a marker that tracks both cognition and cardiac risk. Few inputs offer that ratio.
Map where your system is carrying load
Omega-3 is one input among ten that decide whether your baseline holds or quietly erodes. If the afternoon focus fade, the harder recovery, and the sense that performance costs more than it used to are showing up together, the useful first move is not another supplement but a clear read of where your system is actually carrying load. The free O!Sapiens self-assessment at https://osapiens.expert/capacity maps that across the full picture, so you spend effort where the deficit actually is rather than guessing.
One caveat worth stating plainly. If your focus problems come with persistent low mood, unexplained fatigue that does not lift, or a partner reporting that you snore or gasp in your sleep, that is not a nutrition question and no supplement will fix it. Those point toward things like depression or sleep apnea that need a physician. And if you take blood thinners, are pregnant, or manage a chronic condition, clear any new omega-3 dose with your doctor first, since it can affect bleeding and interacts with some medications.
This is education, not medical advice. O!Sapiens provides coaching and educational content, not diagnosis or treatment. Nothing here is a substitute for care from a qualified professional. Blood testing and supplement decisions should be made with your physician.
You can still perform, but it costs more than it used to. The reports get finished, the calls get taken, yet holding attention through the back half of a long block feels like pushing a car that used to roll on its own. Most executives file this under fatigue or age and move on. Sometimes it is neither. Sometimes it is a supply problem in the raw material your brain and heart are built from, and it is one of the few things you can put an actual number on.
Omega-3 status is a measurable input that sets part of the baseline your brain and cardiovascular system run on, and a low level is a form of hidden biological debt you can see in a single blood test rather than infer from how you feel.
Roughly 76% of people do not carry enough EPA and DHA, the two long-chain omega-3 fats that matter most, according to 2025 global status estimates. In the US, average intake runs near 41 mg of EPA and 72 mg of DHA a day, a small fraction of what most guidance points toward. This is not an exotic deficiency. It is close to the default.
What is actually happening in the tissue?
DHA is not a nice-to-have nutrient floating in your bloodstream. It is a structural component of the membranes your neurons are built from. Membrane composition affects how fluid those membranes are, how cleanly signals pass across synapses, and how well the machinery of a brain cell does its work. When DHA supply is chronically low, the body builds those membranes out of whatever is available, and the substitute materials do not perform the same way.
EPA does a different job. It is a raw material for the molecules that resolve inflammation, and it competes directly with omega-6 fats that push the other direction. A diet heavy in processed food and seed oils and light in fatty fish tilts that balance toward a low-grade inflammatory setting. Your brain and your arteries both operate inside that setting all day.
This is why the same deficit shows up in two systems at once. The cognitive cost and the cardiovascular cost are not separate stories. They are the same supply line feeding two different pieces of your performance infrastructure.
What can you actually measure?
Here is where omega-3 separates itself from most of what gets sold as brain support. There is a validated blood marker, the Omega-3 Index, which measures the EPA and DHA content of your red blood cell membranes as a percentage. It reflects your status over months, not what you ate yesterday, so it is a genuine baseline reading rather than a snapshot.
The number tracks hard outcomes. In a 2025 analysis published in the Journal of Clinical Lipidology, following 2,550 people without cardiovascular disease over ten years, those in the highest Omega-3 Index band (above 6.8%) had a 34% lower risk of death from any cause and a 39% lower risk of a first cardiovascular event compared with those in the lowest (below 4.2%). Omega-3 status held its own alongside long-established risk factors like cholesterol and smoking. That is a rare thing for a nutrient marker.
On the cognitive side, a 2025 dose-response meta-analysis in Scientific Reports pooling 58 studies found that each additional 2,000 mg per day of omega-3 was associated with measurable improvement in attention and perceptual speed, with executive-function benefit concentrated in the first year of consistent intake and strongest in people whose starting levels were not already adequate.
What does the signal mean, and what does it not?
Read the last clause of that finding carefully, because it is the whole game. The benefit shows up mostly in people who were low to begin with. If your level is already in a good range, adding more does little. This is a correction, not an upgrade.
That single fact explains why the headlines look contradictory. Large trials that hand omega-3 to everyone regardless of starting status show mixed, often unimpressive results, while the blood level itself remains a strong predictor of who does well. Both are true. Averaging a group of already-replete people with a group of deficient people washes out an effect that is real in the ones who needed it. The pill count is not the signal. The blood level is.
The second boundary: what moves is attention and processing speed, the ability to hold and sort information over time. This is not a pill that makes you smarter or hands you an extra ten IQ points. It supports the specific function that fades first under load. Do not expect a euphoric switch. A stimulant gives you that feeling by borrowing against recovery capacity. This is the opposite kind of input, quiet and structural.
A word of caution on the marketed version of all this. Omega-3 blood panels are now bundled into expensive executive-health packages alongside dozens of other tests. The value of a test is the share of its findings that are real and actionable, not the length of the report. One relevant, cheap, repeatable marker beats a forty-line panel you will never act on.
What is the minimum that actually moves the number?
The food-first version is genuinely simple. Two to three servings of fatty fish a week (salmon, sardines, mackerel, herring) covers most of the gap for most people, no capsules required. That is a grocery decision, not a supplement regimen.
If fish is not realistic at that frequency, a combined EPA and DHA supplement in the range of roughly 1 to 2 grams a day is the studied territory. Buy on the actual EPA and DHA content listed on the label, not the total fish-oil weight on the front, and treat plain formulations the same way you would any commodity: the branded premium usually buys marketing, not effect. Take it with a meal that contains fat, since absorption depends on it.
Then give it time and check the result. Red blood cell membranes turn over slowly, so the Omega-3 Index responds over two to three months, not two to three days. Test once, adjust intake, retest a season later, and let the trend rather than a single reading tell you whether it worked. That is three to four minutes of blood draw twice a year against a marker that tracks both cognition and cardiac risk. Few inputs offer that ratio.
Map where your system is carrying load
Omega-3 is one input among ten that decide whether your baseline holds or quietly erodes. If the afternoon focus fade, the harder recovery, and the sense that performance costs more than it used to are showing up together, the useful first move is not another supplement but a clear read of where your system is actually carrying load. The free O!Sapiens self-assessment at https://osapiens.expert/capacity maps that across the full picture, so you spend effort where the deficit actually is rather than guessing.
One caveat worth stating plainly. If your focus problems come with persistent low mood, unexplained fatigue that does not lift, or a partner reporting that you snore or gasp in your sleep, that is not a nutrition question and no supplement will fix it. Those point toward things like depression or sleep apnea that need a physician. And if you take blood thinners, are pregnant, or manage a chronic condition, clear any new omega-3 dose with your doctor first, since it can affect bleeding and interacts with some medications.
This is education, not medical advice. O!Sapiens provides coaching and educational content, not diagnosis or treatment. Nothing here is a substitute for care from a qualified professional. Blood testing and supplement decisions should be made with your physician.